63449-37-6

Basic information

• Product Name: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE
• Synonyms: BUTTPARK 94\04-65;ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE;ETHYL 4-(ETHOXYCARBONYLMETHYLTHIO)BUTYRATE;Ethyl 4-[(2-ethoxy-2-oxoethyl)sulphanyl]butanoate, Ethyl 4-[(2-ethoxy-2-oxoethyl)thio]butyrate;Butanoic acid, 4-[(2-ethoxy-2-oxoethyl)thio]-,ethyl ester
• CAS NO: 63449-37-6
• Molecular Formula: C₁₀H₁₈O₄S
• Molecular Weight: 234.31
• Mol File: 63449-37-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 311.3°C at 760 mmHg
• Flash Point: 138.1°C
• Appearance: /
• Density: 1.092g/cm³
• Vapor Pressure: 0.000567mmHg at 25°C
• Refractive Index: 1.47
• CAS DataBase Reference: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE(63449-37-6)
• EPA Substance Registry System: ETHYL 4-[(2-ETHOXY-2-OXOETHYL)THIO]BUTANOATE(63449-37-6)

Safety Data

• Safety Statements: S24/25:Avoid contact with skin and eyes.
• Hazardous Substances Data: 63449-37-6(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H18O4S/c1-3-13-9(11)6-5-7-15-8-10(12)14-4-2/h3-8H2,1-2H3

Upstream product

• 3153-36-4 4-chloro-butyric acid ethyl ester 
• 141-52-6 sodium ethanolate 
• 623-51-8 ethyl 2-sulfanylacetate 
• 2969-81-5 Ethyl 4-bromobutyrate 

Downstream Products

• 97491-86-6 1-Ethoxycarbonyl-1-<4-nitro-phenylhydrazono>-2-thia-n-pentan-carbonsaeure-(5)-ethylester-dioxid-(2.2) 
• 58509-73-2 ethyl 3-oxothiane-2-carboxylate 
• 135369-32-3 ethyl 3-oxotetrahydro-2H-thiopyran-4-carboxylate 
• 19090-03-0 dihydro-2H-thiopyran-3(4H)-one 
• 132030-65-0 7,8-Dihydro-2-cyclohexylamino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 
• 132030-63-8 7,8-Dihydro-2-benzylamino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 
• 132030-64-9 7,8-Dihydro-2-(2-phenylethylamino)-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 
• 135369-47-0 10-Benzyl-6,7-dihydro-2-methylthio-5H,10H-thiopyrano<2,3-e>-1,2,4-triazolo<1,5-a>pyrimidin-9-one 
• 135369-44-7 10-Benzyl-7,8-dihydro-2-methylthio-5H,10H-thiopyrano<4,3-e>-1,2,4-triazolo<1,5-a>pyrimidin-9-one 
• 135369-49-2 10-Benzyl-7,8-dihydro-2-dimethylamino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimdin-5-one 
• 135369-43-6 10-Benzyl-6,7-dihydro-2-methylthio-9H,10H-thiopyrano<3,4-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 
• 135369-46-9 10-Benzyl-7,8-dihydro-2-methylthio-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 
• 135369-51-6 10-Benzyl-7,8-dihydro-2-diethylamino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimdin-5-one 
• 135369-55-0 10-Benzyl-7,8-dihydro-2-benzylamino-9H,10H-thiopyrano<3,2-d>-1,2,4-triazolo<1,5-a>pyrimidin-5-one 

Relevant articles and documents

SUBSTITUTED PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula (I-1) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

MORPHOLINO SUBSTITUTED BICYCLIC PYRIMIDINE UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS

The invention relates to compounds of formula (I) wherein m, o, Ra, Rb, R1 and T1 have the meaning as cited in the description and the claims. Said compounds are useful as inhibitors of mTOR for the treatment or prophylaxis of mTOR related diseases and disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the use as medicaments